The Kratom Consumer Protection Act (KCPA) Explained

As states have debated what to do about kratom, two broad approaches have emerged: ban it, or regulate it. The Kratom Consumer Protection Act (KCPA) is the main model for regulation. Here is what it is, what it typically requires, which states have adopted versions of it, and what supporters and critics say.

What is the Kratom Consumer Protection Act?

The KCPA is model state legislation developed and promoted by the American Kratom Association (AKA), a consumer advocacy organization. Rather than prohibiting kratom, it sets rules for how kratom products are made, labeled and sold. Each state that adopts a KCPA writes its own version, so the details vary.

What KCPA laws usually require

Minimum age. Sales are limited to adults, usually 18 or 21.
Labeling. Products must list ingredients, alkaloid content and the manufacturer, often with usage directions and warnings.
No adulteration. Products cannot be mixed with controlled substances or other dangerous ingredients.
Limits on concentrated alkaloids. Many versions cap the amount of 7-OH a product can contain or ban synthetic alkaloids outright.
Testing. Some states require testing for contaminants such as heavy metals and microbes.
Registration or licensing. Some states require manufacturers or retailers to register, and they can penalize violators.

States with KCPA-style laws

Utah, Georgia, Nevada and Arizona were among the first to adopt the KCPA, starting in 2019. Since then, versions have passed in states including Oklahoma, Florida, Texas, Colorado and others, and several more have considered it.

The most notable recent example is Rhode Island. After banning kratom in 2017, the state enacted the Rhode Island Kratom Act, which took effect April 1, 2026, and replaced the ban with a licensing system. It limits sales to people 21 and older, requires products to be kept behind the counter, and caps mitragynine per serving and 7-OH per gram and per serving.

Because state laws change often, check our state-by-state legal guide and your state’s official sources for current status.

The AKA GMP Standards Program

Separately from state law, the AKA runs a voluntary Good Manufacturing Practice (GMP) Standards Program for vendors. Companies that meet its standards for manufacturing, testing and labeling can be listed as GMP qualified. It is not a government certification, but it can be one useful signal when comparing vendors. Our guide on reading a kratom label covers what to check.

Arguments for the KCPA approach

Regulation keeps products on the legal market where they can be tested and labeled, rather than pushing sales underground.
Age limits and labeling give consumers more information and protect minors.
Limits on 7-OH and synthetic alkaloids target the products regulators are most worried about.

Criticisms and limitations

Some public health officials and law enforcement groups argue that kratom’s risks, including dependence, justify a ban.
Enforcement depends on state resources, and labeling rules only help if they are checked.
Some states that passed regulation have later considered reversing course toward a ban.
Critics also note that the model law originated with an advocacy group connected to the kratom market.

Frequently asked questions

Who created the Kratom Consumer Protection Act?

The American Kratom Association developed it as model legislation for states to adopt.

Does the KCPA make kratom legal?

In states that adopt it, the KCPA sets a regulated framework for legal sale. It does not override bans in other states.

Does the KCPA ban 7-OH?

Many versions cap 7-OH content or ban synthetic alkaloids, but the details depend on each state’s law. See Kratom vs. 7-OH.

Sources

Kratom Universe publishes independent educational information. Nothing on this site is medical or legal advice. Kratom is not approved by the FDA to diagnose, treat, cure or prevent any disease. Talk with a healthcare provider before using kratom, and check your state and local laws. If you or someone you know is struggling with substance use, call SAMHSA’s free, confidential National Helpline at 1-800-662-4357.